Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 14.18
MGLN's Cash to Debt is ranked higher than
91% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.53 vs. MGLN: 14.18 )
MGLN' s 10-Year Cash to Debt Range
Min: 0.03   Max: 15614.18
Current: 14.18

0.03
15614.18
Equity to Asset 0.66
MGLN's Equity to Asset is ranked higher than
91% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.39 vs. MGLN: 0.66 )
MGLN' s 10-Year Equity to Asset Range
Min: -0.57   Max: 0.74
Current: 0.66

-0.57
0.74
Interest Coverage 55.40
MGLN's Interest Coverage is ranked higher than
92% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.20 vs. MGLN: 55.40 )
MGLN' s 10-Year Interest Coverage Range
Min: 2.26   Max: 99.13
Current: 55.4

2.26
99.13
F-Score: 4
Z-Score: 5.05
M-Score: -2.02
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 4.69
MGLN's Operating margin (%) is ranked higher than
79% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.65 vs. MGLN: 4.69 )
MGLN' s 10-Year Operating margin (%) Range
Min: -2.01   Max: 9.77
Current: 4.69

-2.01
9.77
Net-margin (%) 3.53
MGLN's Net-margin (%) is ranked higher than
85% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.89 vs. MGLN: 3.53 )
MGLN' s 10-Year Net-margin (%) Range
Min: -41.59   Max: 29.9
Current: 3.53

-41.59
29.9
ROE (%) 10.83
MGLN's ROE (%) is ranked higher than
73% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.83 vs. MGLN: 10.83 )
MGLN' s 10-Year ROE (%) Range
Min: -106.04   Max: 116.46
Current: 10.83

-106.04
116.46
ROA (%) 7.12
MGLN's ROA (%) is ranked higher than
97% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.84 vs. MGLN: 7.12 )
MGLN' s 10-Year ROA (%) Range
Min: -72.61   Max: 34.97
Current: 7.12

-72.61
34.97
ROC (Joel Greenblatt) (%) 53.72
MGLN's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 134.04 vs. MGLN: 53.72 )
MGLN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -3.67   Max: 197.97
Current: 53.72

-3.67
197.97
Revenue Growth (%) 14.10
MGLN's Revenue Growth (%) is ranked higher than
79% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.90 vs. MGLN: 14.10 )
MGLN' s 10-Year Revenue Growth (%) Range
Min: -10.5   Max: 19.4
Current: 14.1

-10.5
19.4
EBITDA Growth (%) 2.30
MGLN's EBITDA Growth (%) is ranked higher than
62% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.80 vs. MGLN: 2.30 )
MGLN' s 10-Year EBITDA Growth (%) Range
Min: -28.1   Max: 34.9
Current: 2.3

-28.1
34.9
EPS Growth (%) 4.00
MGLN's EPS Growth (%) is ranked higher than
67% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.00 vs. MGLN: 4.00 )
MGLN' s 10-Year EPS Growth (%) Range
Min: -47.7   Max: 316.8
Current: 4

-47.7
316.8
» MGLN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

MGLN Guru Trades in Q1 2013

Paul Tudor Jones 11,900 sh (New)
Chuck Royce 1,296,336 sh (+43.87%)
Jim Simons 1,128,171 sh (+5.25%)
Joel Greenblatt Sold Out
RS Investment Management 1,250,639 sh (-8.16%)
Steven Cohen 415,999 sh (-60.94%)
» More
Q2 2013

MGLN Guru Trades in Q2 2013

Chuck Royce 1,296,786 sh (+0.03%)
Paul Tudor Jones Sold Out
RS Investment Management 1,104,468 sh (-11.69%)
Jim Simons 982,499 sh (-12.91%)
Steven Cohen 98,274 sh (-76.38%)
» More
Q3 2013

MGLN Guru Trades in Q3 2013

Joel Greenblatt 3,820 sh (New)
Paul Tudor Jones 6,500 sh (New)
Chuck Royce 1,300,416 sh (+0.28%)
Jim Simons 919,499 sh (-6.41%)
RS Investment Management 685,536 sh (-37.93%)
Steven Cohen 32,391 sh (-67.04%)
» More
Q4 2013

MGLN Guru Trades in Q4 2013

Paul Tudor Jones 16,582 sh (+155.11%)
Jim Simons 1,047,499 sh (+13.92%)
RS Investment Management 762,081 sh (+11.17%)
Joel Greenblatt 3,795 sh (-0.65%)
Chuck Royce 1,159,648 sh (-10.82%)
Steven Cohen 6,472 sh (-80.02%)
» More
» Details

Insider Trades

Latest Guru Trades with MGLN

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-09-30 New Buy0.01%$55.69 - $59.97 $ 55.13-5%3820
Joel Greenblatt 2013-03-31 Sold Out 0.01%$47.45 - $54.23 $ 55.137%0
Joel Greenblatt 2012-12-31 Reduce -53.6%0.02%$47.48 - $53.52 $ 55.139%4119
Joel Greenblatt 2012-09-30 Reduce -86.65%0.19%$44.98 - $55.89 $ 55.1312%8878
Joel Greenblatt 2012-06-30 Add 22.82%0.04%$40.78 - $49.85 $ 55.1325%66503
Joel Greenblatt 2012-03-31 Add 73.43%0.1%$46.3 - $50.15 $ 55.1321%54148
Joel Greenblatt 2011-09-30 Add 43.04%0.06%$41.85 - $56.13 $ 55.1311%27164
Joel Greenblatt 2011-03-31 Add 152.8%0.2%$46.05 - $51.42 $ 55.1314%22135
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 12.20
MGLN's P/E(ttm) is ranked higher than
86% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.30 vs. MGLN: 12.20 )
MGLN' s 10-Year P/E(ttm) Range
Min: 3.33   Max: 22.89
Current: 12.2

3.33
22.89
P/B 1.30
MGLN's P/B is ranked higher than
73% of the 30 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.80 vs. MGLN: 1.30 )
MGLN' s 10-Year P/B Range
Min: 1.13   Max: 2.96
Current: 1.3

1.13
2.96
P/S 0.43
MGLN's P/S is ranked higher than
64% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.42 vs. MGLN: 0.43 )
MGLN' s 10-Year P/S Range
Min: 0.39   Max: 1.12
Current: 0.43

0.39
1.12
PFCF 12.80
MGLN's PFCF is ranked higher than
76% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.23 vs. MGLN: 12.80 )
MGLN' s 10-Year PFCF Range
Min: 4.16   Max: 26.28
Current: 12.8

4.16
26.28
EV-to-EBIT 7.00
MGLN's EV-to-EBIT is ranked higher than
77% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.40 vs. MGLN: 7.00 )
MGLN' s 10-Year EV-to-EBIT Range
Min: 3.7   Max: 12.8
Current: 7

3.7
12.8
PEG 1.40
MGLN's PEG is ranked higher than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.80 vs. MGLN: 1.40 )
MGLN' s 10-Year PEG Range
Min: 0.56   Max: 4.71
Current: 1.4

0.56
4.71
Shiller P/E 13.60
MGLN's Shiller P/E is ranked higher than
86% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.00 vs. MGLN: 13.60 )
MGLN' s 10-Year Shiller P/E Range
Min: 7.36   Max: 17.5
Current: 13.6

7.36
17.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.50
MGLN's Price/Tangible Book is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.90 vs. MGLN: 2.50 )
MGLN' s 10-Year Price/Tangible Book Range
Min: 2.41   Max: 19.98
Current: 2.5

2.41
19.98
Price/DCF (Projected) 0.50
MGLN's Price/DCF (Projected) is ranked higher than
92% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.80 vs. MGLN: 0.50 )
MGLN' s 10-Year Price/DCF (Projected) Range
Min: 0.42   Max: 1.2
Current: 0.5

0.42
1.2
Price/Median PS Value 0.70
MGLN's Price/Median PS Value is ranked higher than
94% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. MGLN: 0.70 )
MGLN' s 10-Year Price/Median PS Value Range
Min: 0.73   Max: 1.7
Current: 0.7

0.73
1.7
Price/Peter Lynch Fair Value 0.90
MGLN's Price/Peter Lynch Fair Value is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.90 vs. MGLN: 0.90 )
MGLN' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.62   Max: 1.4
Current: 0.9

0.62
1.4
Price/Graham Number 1.20
MGLN's Price/Graham Number is ranked higher than
83% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.80 vs. MGLN: 1.20 )
MGLN' s 10-Year Price/Graham Number Range
Min: 0.98   Max: 4.02
Current: 1.2

0.98
4.02
Earnings Yield (Greenblatt) 14.20
MGLN's Earnings Yield (Greenblatt) is ranked higher than
79% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. MGLN: 14.20 )
MGLN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 7.8   Max: 27.2
Current: 14.2

7.8
27.2
Forward Rate of Return (Yacktman) 20.75
MGLN's Forward Rate of Return (Yacktman) is ranked higher than
83% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.82 vs. MGLN: 20.75 )
MGLN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.9   Max: 26.3
Current: 20.75

-5.9
26.3

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, HUM, AET » details
Traded in other countries:MAH1.Germany
Magellan Health Services, Inc., a Delaware corporation was incorporated in 1969. The Company provides specialty healthcare services. The Company's business is divided into six segments, based on the services it provides and/or the customers that it serves. Managed Behavioral Healthcare, two of the Company's segments are in the managed behavioral healthcare business. This line of business generally reflects the Company's coordination and management of the delivery of behavioral healthcare treatment services that are provided through its contracted network of third-party treatment providers, which includes psychiatrists, psychologists, other behavioral health professionals, psychiatric hospitals, general medical facilities with psychiatric beds, residential treatment centers and other treatment facilities. The treatment services provided through the Company's provider network include outpatient programs (such as counseling or therapy), intermediate care programs (such as intensive outpatient programs and partial hospitalization services), inpatient treatment and crisis intervention services. The managed behavioral healthcare business is managed based on the services provided and/or the customers served, through the following two segments: Commercial and Public Sector. The Radiology Benefits Management segment generally reflects the management of the delivery of diagnostic imaging services to ensure that such services are clinically appropriate and cost effective. The Company's radiology benefits management services currently are provided under contracts with health plans and insurance companies for some or all of their commercial, Medicaid and Medicare members. The Company also contracts with state and local governmental agencies for the provision of such services to Medicaid recipients. The Specialty Pharmaceutical Management segment generally reflects the management of specialty drugs used in the treatment of cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis and other diseases. Specialty pharmaceutical drugs represent high-cost injectible, infused, oral, or inhaled drugs often with sensitive handling or storage needs. The Medicaid Administration segment generally reflects integrated clinical management services provided to the public sector to manage Medicaid, pharmacy, mental health and long-term care programs. The Company's Medicaid Administration services include the management of pharmacy benefits administration ('PBA'), medical management information services and fiscal agent services ('FAS'), and health care management services ('HCM'). This segment of the Company is comprised mainly of operational support functions such as sales and marketing and information technology, as well as corporate support functions such as executive, finance, human resources and legal. The Company's business is competitive. The Company competes with other healthcare organizations as well as with

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide